Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Gastroenterology > Gastroenterology Alagille Syndrome Panel

Alagille Syndrome Panel

The Igenomix Alagille Syndrome Panel can be used to make a directed and accurate differential diagnosis of jaundice in the newborn, for an early initiation of treatment leading to a better prognosis of the disease. 
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • The Igenomix Alagille Syndrome Panel can be used to make a directed and accurate differential diagnosis of jaundice in the newborn, for an early initiation of treatment leading to a better prognosis of the disease.  
  • Alagille syndrome is a disorder that is associated with problems in several different body organs including – liver disease, congenital heart conditions, abnormalities in the eye and characteristic facial features.
  • Alagille syndrome can present differently, and the clinical symptoms of affected individuals can be very variable. It is characterized by an obstruction of the biliary tree and decreased excretion of bilirubin causing hyperbilirubinemia and jaundice.
  •  The different manifestations of Alagille syndrome can be deadly if treatment and management is not administered appropriately. This condition is inherited in an autosomal dominant manner and most cases occur due to a de novo variant. Additionally, Alagille syndrome is associated with variable expression and so the clinical features cannot be predicted with molecular testing.  

Indication

The Igenomix Alagille Syndrome Panel is indicated for those patients with a clinical suspicion  or diagnosis of the disease, presenting with the following symptoms: 

  • Hepatic anomalies  
  • Renal anomalies  
  • Cardiac anomalies  
  • Characteristic facial features  
  • Eye problems  
  • Bile duct paucity  
  • Abnormality in the vertebrae  

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular diagnosis for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team. 
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

Methodology

References

See scientific referrals

Mitchell, E., Gilbert, M., & Loomes, K. M. (2018). Alagille Syndrome. Clinics in liver disease, 22(4), 625–641. https://doi.org/10.1016/j.cld.2018.06.001 

Turnpenny, P. D., & Ellard, S. (2012). Alagille syndrome: pathogenesis, diagnosis and management. European journal of human genetics: EJHG, 20(3), 251–257. https://doi.org/10.1038/ejhg.2011.181 

Ayoub, M. D., & Kamath, B. M. (2020). Alagille Syndrome: Diagnostic Challenges and Advances in Management. Diagnostics (Basel, Switzerland), 10(11), 907. https://doi.org/10.3390/diagnostics10110907 

Ohashi, K., Togawa, T., Sugiura, T., Ito, K., Endo, T., Aoyama, K., Negishi, Y., Kudo, T., Ito, R., & Saitoh, S. (2017). Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome and incomplete Alagille syndrome. Acta paediatrica (Oslo, Norway : 1992), 106(11), 1817–1824. https://doi.org/10.1111/apa.13981 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information